Former Gilead CEO and current Chairman John Martin (Paul Sakuma / AP)

Gilead's top executives continue to reap the benefits of the blockbuster hepatitis C drugs it acquired several years ago. In 2016, according to proxy documents filed with the Securities and Exchange Commission on Monday, Gilead paid:

  • John Martin: $98.4 million
  • John Milligan: $57.8 million

Those figures represent the actual value of stock vested in 2016, not estimated fair value.

Milligan took over as CEO in March 2016, replacing Martin, who now serves as executive chairman. Martin has taken home $523 million since 2014, when Gilead started selling both of its hepatitis C drugs, Sovaldi and Harvoni. A vast majority of Martin's pay has come in the form of cashed-in stock.

Why this matters: Gilead's executive pay fans the flames of the U.S. drug pricing debate. Consumers and lawmakers have lambasted the company, arguing the high drug prices are unjustified and lock people out of medicine that cures hepatitis C. The list prices are $84,000 for Sovaldi and $94,500 for Harvoni, or more than $1,000 per pill for the usual 12-week treatment, but after discounts and rebates the price is a little more than half that.

Go deeper

Zeta, now a Category 2 Hurricane, makes landfall on Louisiana coast

The probable path of Zeta, per the National Hurricane Center. Photo: NHC/NOAA

Zeta, classified as a "significant" Category 2 hurricane, made landfall along the southeastern coast of Louisiana on Wednesday evening, according to the National Hurricane Center.

The state of play: Louisiana Gov. John Bel Edwards (D) requested a pre-landfall Emergency Declaration in a letter to President Trump on Tuesday. The hurricane is producing 110-mph maximum sustained winds and stronger gusts. The core of Zeta — including its destructive eyewall — moved ashore near Cocodrie.

Supreme Court won't expedite Pennsylvania GOP's request to block mail-in ballot extension

Amy Coney Barrett being sworn in by Chief Justice John Roberts. Photo: Fred Schilling/Collection of the Supreme Court of the United States via Getty Images

The Supreme Court voted 5-3 on Wednesday to deny a bid from Pennsylvania Republicans to expedite their request to shorten the deadline for receiving mail-in ballots. Newly-confirmed Justice Amy Coney Barrett did not participate in the decision.

Why it matters: A lower court ruling allowing ballots to be counted until 5 p.m. on Nov. 6, as long as they are postmarked by Election Day, will remain in place for now.

27 mins ago - World

Europe faces "stronger and deadlier" coronavirus wave

Paris under curfew. Photo: Kiran Ridley/Getty Images

The coronavirus is still winning: Now even Germany is entering another national lockdown, joined by France.

Why it matters: France has been "overpowered by a second wave,” President Emmanuel Macron said in a nationally televised address today. Macron said the "new wave will be stronger and deadlier" than the first.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!